# Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities

> **NCT05361941** · NA · RECRUITING · sponsor: **Elute, Inc.** · enrollment: 204 (estimated)

## Conditions studied

- Periprosthetic Joint Infections

## Interventions

- **DEVICE:** EP Granules with Tobramycin
- **DEVICE:** empty voids

## Key facts

- **NCT ID:** NCT05361941
- **Lead sponsor:** Elute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-31
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 204 (ESTIMATED)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05361941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05361941, "Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05361941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*